Macquarie Group LTD Novo Nordisk A S Transaction History
Macquarie Group LTD
- $87.4 Billion
- Q1 2024
A detailed history of Macquarie Group LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Macquarie Group LTD holds 181 shares of NVO stock, worth $26,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181
Previous 178
1.69%
Holding current value
$26,152
Previous $18,000
27.78%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NVO
# of Institutions
1,853Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3.05 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.98 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.89 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.74 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.71 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $326B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...